Atlas Trials

The Guiding Value of Liquid Biopsy Based on Urinary Tumor DNA/RNA in the Second Transurethral Resection of High-risk Non-muscle Invasive Bladder Cancer

Clinical trial NCT07130578 · RECRUITING

Trial details

NCT number
NCT07130578
Sponsor
Tianjin Medical University Second Hospital
Status
RECRUITING
Study type
OBSERVATIONAL
Bladder CancerLiquid Biopsy
Start date
2025-09-01
Primary completion
2026-11-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.